Litigation Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)
✉ Email this page to a colleague
BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-03-01 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | Christopher J. Burke |
| Parties | INTELGENX CORP. | ||
| Patents | 6,159,498; 6,200,604; 6,264,981; 6,277,384; 6,696,066; 6,759,059; 7,579,019; 8,147,866; 8,703,177; 9,597,288; 9,655,843; 9,901,539 | ||
| Attorneys | Lauren A. Watt | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BioDelivery Sciences International, Inc. v. Chemo Research, S.L.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in BioDelivery Sciences International, Inc. v. Chemo Research, S.L.
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for BioDelivery Sciences International, Inc. v. Chemo Research, S.L. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-03-01 | 1 | Exhibit A-C | crosslinked and/or plasticized in order to alter 6,159,498, U.S. Pat. No. 5,800,832, U.S. Pat. No. 6,585,…0168147 A1 7/2010 Chapleo et al. 6,159,498 A 12/2000 Tapolsky et al. …Pat. its dissolution kinetics. No. 6,159,498, U.S. Pat. No. 5,800,832, U.S. Pat. No. … (12) United States Patent (10) Patent No.: …experienced mucosal irrita including, patents, patent applications, articles, books, trea tion | External link to document |
| 2019-04-19 | 11 | Answer to Complaint | invalidity of U.S. Patents Nos. 8,147,866 (“the ’866 patent”), 9,655,843 (“the ’843 patent”), and 9,901,539…noninfringement of U.S. Patent Nos. 8,147,866 (“the ’866 patent”), 9,655,843 (“the ’843 patent”), and 9,901,539…COUNT I FOR PATENT INFRINGEMENT (Infringement of U.S. Patent No. 8,147,866 (“the ’866…,539 (“the ’539 patent”) (collectively, “the Patents-in-Suit”). 1 Plaintiffs’…this purports to be an action for patent infringement under the patent laws of the United States, Title | External link to document |
| 2020-01-06 | 121 | Exhibit A-D | International Patent Application Publication WO 00/62764 (“Yates”) x U.S. Patent No. 6,159,498 (“Tapolsky… (ii) Tapolsky II U.S. Patent No. 6,159,498 (“Tapolsky II”) issued on December 12, 2000… of U.S. Patent No. 9,655,843 (“the ’843 patent”), and claims 1-7 and 9-22 of U.S. Patent No. 9,901,539…the asserted patents or any related patent in any other forum or the United States Patent and Trademark… x U.S. Patent No. 4,713,243 x U.S. Patent No. 4,784,858 x U.S. Patent No. 5,780,047 | External link to document |
| 2020-01-17 | 134 | Exhibit E-I | asserted U.S. Patent Nos. 8,147,866 (“the ’866 patent”); 9,655,843 (“the ’843 patent”); and 9,901,539…are not indefinite. I. U.S. Patent No. 8,147,866 Claim Term … U.S. Patent No. 8,147,866 Claim(s) Term/Phrase Defendants…'s U.S. Patent Number 6,175,014, 7 hereinafter the "'014 Patent," and plaintiff…, 2001, the U.S. Patent and Trademark 18 Office issued the '014 Patent, entitled "Process | External link to document |
| 2020-04-15 | 243 | Redacted Document | of U.S. Patent No. 7,579,019 (including applications that led to U.S. Patent No. 7,579,019 and any … of U.S. Patent No. 7,579,019 (including applications that led to U.S. Patent No. 7,579,019 and any foreign… discovery concerning U.S. Patent No. 7,579,019 (“the ’019 Patent”), even though BDSI asserts…Osborne are the named inventors of U.S. Patent No. 7,579,019, a patent that is not at issue in the present…subject.” (U.S. Patent No. 7,579,019 at Claim 1). BDSI caused the ’019 patent to be listed in | External link to document |
| 2019-02-28 | 3 | ANDA Form | 2019 Date of Expiration of Patent: Patent No. 8,147,866: July 23, 2027 … Patent No. 9,655,843: July 23, 2027 Patent No. 9,… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 7/31/19. Date of Expiration of Patent: SEE ATTACHED.Thirty Month Stay Deadline: 8/1/2021… ) SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG | External link to document |
| 2019-08-01 | 38 | Complaint for Patent Infringement (D.I. 1). The Asserted Patents are U.S. Patent Nos. 8,147,866; 9,655,843… asserted patent; (d) All documents evidencing ownership of the patent rights by … i. Each claim of each asserted patent that is allegedly infringed by …and v. For any patent that claims priority to an earlier application,…prior to the date of application for the asserted patent(s); (b) All documents evidencing | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
